4C Medical Technologies
Mr. Chen is the Chief International Business Officer at MicroPort. Before this appointment, he has served as the Executive Vice President of International Operations and Investor Relations. Mr. Chen's primary responsibilities include growing the company's international business markets in the U.S., Europe, and South America. Prior to joining the MicroPort, Mr. Chen worked for Angiotech Pharmaceuticals, Inc. for 6 years where he was Senior Vice President of Business Development. He led the management team to build a $300 million medical products business through various acquisitions and licensing transactions. Preceding Angiotech, Mr. Chen was a life sciences investment banker for Credit Suisse and Alex. Brown & Sons. He helped his clients raise more than $2 billion in equity and debt capital and advised on over $3 billion in Mergers & Acquisitions transactions.
Mr. Chen holds a Bachelor of Arts degree in Economics and a Bachelor of Sciences degree with honors in Biological Sciences from Stanford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
4C Medical Technologies
4C Medical Technologies is a medical device company that develops minimally invasive therapies for structural heart disease.